Please login to your online account to display your discounted pricing

anti-DLL3, Polyclonal, Novus Biologicals™


Manufacturer: novus biologicals canada  NBP224669SS

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NBP224669SS

  • / Each
 

Description & Specifications

Specifications

Gene ID (Entrez) 10683
Gene Accession No. Q9NYJ7
Host Species Rabbit
Cross Reactivity Human
Cross Reactivity Mouse
Cross Reactivity Primate
Formulation 100μg antibody in 200μL PBS containing 0.05% BSA
Test Specificity The amino acid sequence used as immunogen is 100% homologous in human and monkey, 83% homologous in cat, 81% homologous in bovine and 72% homologous in mouse and rat. IMG-6242A detects the expected approximately 23 kD band in mouse and rat skeletal muscle tissue lysate, but additional larger molecular weight bands may be seen.
Conjugate Unlabeled
Concentration 0.5mg/mL
Regulatory Status RUO
Quantity 0.025mg
Applications Immunohistochemistry (Paraffin)
Applications Western Blotting
Primary or Secondary Primary
Immunogen A portion of amino acid 100 to 150 of human DLL3 was used as immunogen for the antibody.
Monoclonal or Polyclonal Polyclonal
Format Purified
Antigen DLL3